Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- systolic blood pressure (BP) ≥130 mmHg or diastolic BP ≥80 mmHg
- retinopathy
Otros factores de diagnóstico
- headache
- visual changes
- dyspnea
- chest pain
- sensory or motor deficit
Factores de riesgo
- obesity
- aerobic exercise <3 times/week
- alcohol intake
- metabolic syndrome
- diabetes mellitus
- black ancestry
- age >60 years
- family history of hypertension or chronic coronary disease
- sleep apnea
- sodium intake >1.5 g/day
- low fruit and vegetable intake
- dyslipidemia
- smoking
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- urinary albumin-to-creatinine ratio (UACR)
- ECG
- fasting metabolic panel with estimated GFR
- lipid panel
- urinalysis
- hemoglobin
- thyroid-stimulating hormone
Pruebas diagnósticas que deben considerarse
- plasma renin activity
- plasma aldosterone
- renal duplex ultrasound/MRA renal arteries/CT angiography
- 24-hour urine pheochromocytoma screen
- plasma fractionated metanephrines
- 24-hour urine free cortisol
- sleep study
- echocardiography
Algoritmo de tratamiento
without chronic renal disease or cardiovascular disease (CVD)-related comorbidity: stage 1 hypertension and lower CVD risk and without diabetes
without chronic renal disease or cardiovascular disease (CVD)-related comorbidity: higher CVD risk or with diabetes
concomitant chronic coronary disease without congestive heart failure
concomitant heart failure (HF)
concomitant left ventricular hypertrophy without chronic coronary disease
concomitant chronic renal disease without cardiovascular disease
concomitant atrial fibrillation without other comorbidity
refractory/resistant to optimized triple therapy at any stage
Colaboradores
Autores
Jeffrey Brettler, MD, FASH
Internal Medicine
Regional Hypertension Co-lead, Kaiser Permanente Southern California, Los Angeles
Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA
Divulgaciones
JB declares that he has no competing interests.
Agradecimientos
Dr Jeffrey Brettler would like to gratefully acknowledge Dr Joel Handler, Dr Jonathan N. Bella, Dr Moustapha Atoui, Dr Liran Blum, and Dr Michael A. Spinelli, previous contributors to this topic.
Divulgaciones
JH, JNB, MA, LB, and MAS declare that they have no competing interests.
Revisores por pares
Isla Mackenzie, MBChB, PhD, FRCP
Clinical Senior Lecturer in Clinical Pharmacology and Honorary Consultant Physician
University of Dundee
Dundee
UK
Divulgaciones
IM is an elected member of the British Hypertension Society Executive Committee.
Syed Wamique Yusuf, MRCPI, FACC
Associate Professor
Department of Cardiology
University of Texas MD Anderson Cancer Center
Houston, TX
Divulgaciones
SWY declares that he has no competing interests.
Melvin Lobo, MBChB, PhD, MRCP
Director Barts Blood Pressure Centre of Excellence
NHS Reader in Cardiovascular Medicine
Department of Clinical Pharmacology
William Harvey Heart Centre
London
UK
Divulgaciones
ML is a consultant for ROX Medical. ML receives honorarium from Cardiosonic, St. Jude Medical, and institutional grant/research support from Medtronic.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024 Oct 7;45(38):3912-4018.Texto completo
Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2025 Nov 4;86(18):1567-678.Texto completo Resumen
Rabi DM, McBrien KA, Sapir-Pichhadze R, et al. Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020 May;36(5):596-624.Texto completo Resumen
Wright JT Jr, Williamson JD, Whelton PK, et al; SPRINT Research Group. A randomized trial of intensive versus standard blood pressure control. N Engl J Med. 2015 Nov 26;373(22):2103-16.Texto completo Resumen
Williams B, MacDonald TM, Morant S, et al; British Hypertension Society's PATHWAY Studies Group. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015 Nov 21;386(10008):2059-68.Texto completo Resumen
Rosendorff C, Lackland DT, Allison M, et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Hypertension. 2015 Jun;65(6):1372-407.Texto completo Resumen
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Drug-induced hypertension
- Chronic kidney disease
- Renal artery stenosis
Más DiferencialesGuías de práctica clínica
- Standards of care in diabetes
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation, and management of high blood pressure in adults
Más Guías de práctica clínicaFolletos para el paciente
Understanding your blood pressure reading
Más Folletos para el pacienteCalculadoras
2021 race-free CKD-EPI equations for glomerular filtration rate (GFR)
Glomerular Filtration Rate Estimate by the IDMS-Traceable MDRD Study Equation
Más CalculadorasVideos
How to perform an ECG: animated demonstration
Más vídeosInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad